Achieve Life Sciences Inc Share Price Nasdaq
Equities
US68230A1060
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 170M 13.11B |
---|---|---|---|---|---|
Net income 2024 * | -34M -2.62B | Net income 2025 * | -39M -3.01B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.49
x | P/E ratio 2025 * |
-5.26
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.31% |
Latest transcript on Achieve Life Sciences Inc
Managers | Title | Age | Since |
---|---|---|---|
John Bencich
CEO | Chief Executive Officer | 47 | 31/07/14 |
Richard Stewart
CHM | Chairman | 65 | 30/04/15 |
Cindy Jacobs
PSD | President | 66 | 31/07/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 13/03/22 |
Thomas King
BRD | Director/Board Member | 69 | 28/03/23 |
Cindy Jacobs
PSD | President | 66 | 31/07/08 |
1st Jan change | Capi. | |
---|---|---|
+27.42% | 46.56B | |
+45.38% | 41.67B | |
+0.48% | 41.16B | |
+32.66% | 32.4B | |
+20.96% | 28.18B | |
-6.35% | 28.1B | |
+48.94% | 14.52B | |
+48.30% | 13.74B | |
+2.97% | 12.17B |